Abstract:Abnormal spindle-like microcephaly-associated (ASPM) protein is essential for mitotic spindle function during cell replication. The present study aimed to evaluate the hypothesis that ASPM serves a critical role in cancer invasiveness and may act as a prognostic biomarker in bladder cancer. In total, 6 independent worldwide bladder cancer microarray mRNA expression datasets (n=1,355) with clinical and follow-up annotations were collected from the Gene Expression Omnibus (GEO) and The Cancer Genome Atlas (TCGA) databases. Reverse transcription-quantitative polymerase chain reaction analysis revealed that ASPM mRNA expression was higher in bladder cancer tissue compared with adjacent normal bladder mucosae in 10 paired human tissue samples (P=0.004). ASPM overexpression in human bladder cancer samples was consistent with the mRNA expression datasets from GEO and TCGA. Bioinformatics analysis indicated that ASPM mRNA expression was significantly associated with grade and tumor node metastasis (TNM) stage in bladder cancer, based on pooled GEO and TCGA datasets (P<0.05). Stratification analysis indicated that the clinical significance of ASPM was particularly pronounced in low-grade or papillary subtypes of bladder cancer. Individual Cox and pooled Kaplan-Meier analyses suggested that ASPM expression was significantly directly correlated with poor overall (OS) and progression-free survival (PFS) in bladder cancer. Multivariate and stratification analyses demonstrated that the prognostic significance of ASPM was evident in low-grade or papillary bladder cancers, yet not in high-grade or non-papillary subgroups. Increased expression of ASPM was associated with poor OS in muscle-invasive bladder cancer and with poor PFS in non-muscle-invasive bladder cancer (P<0.05). Bioinformatics analysis identified the top 11 ASPM-related genes on STRING-DB.org. The expression of the majority of these genes was associated with poor outcomes of bladder cancer with statistical significance. Gene set enrichment analysis indicated that the high expression of ASPM could enrich gene signatures involved in mitosis, differentiation and metastasis in bladder cancer. Further analysis of TCGA datasets indicated that increased ASPM expression was significantly associated with higher Gleason score, T stage, N stage and poor clinical outcome in prostate cancer. It was also significantly associated with late TNM stage and poor PFS in renal cell carcinoma. In summary, ASPM may serve as a novel prognostic biomarker for low-grade or papillary bladder cancer.

Aberrant FoxM1 Expression Increases ASPM Transcription and Promotes the Malignant Properties of Gliomas

Aberrant ASPM Expression Mediated by Transcriptional Regulation of FoxM1 Promotes the Progression of Gliomas

Overexpression of the ASPM Gene is Associated with Aggressiveness and Poor Outcome in Bladder Cancer.

ASPM promotes glioblastoma growth by regulating G1 restriction point progression and Wnt--catenin signaling

ASPM promotes glioblastoma growth by regulating G1 restriction point progression and Wnt-β-catenin signaling

FoxM1 drives ADAM17/EGFR activation loop to promote mesenchymal transition in glioblastoma

Aberrantly high activation of a FoxM1–STMN1 axis contributes to progression and tumorigenesis in FoxM1-driven cancers

FoxM 1 Drives a Feed-Forward STAT 3-Activation Signaling Loop That Promotes the Self-Renewal and Tumorigenicity of Glioblastoma Stem-like Cells

Abstract 2099: FoxM1 Drives a Feed-Forward STAT3-activation Signaling Loop to Promote the Self-Renewal and Tumorigenicity of Glioblastoma Stem Cells

Foxm1b Regulates Nedd4-1 Expression, Leading To Cellular Transformation And Full Malignant Phenotype In Immortalized Human Astrocytes

Over‐expression of FoxM1 Leads to Epithelial–mesenchymal Transition and Cancer Stem Cell Phenotype in Pancreatic Cancer Cells

FOXM1 Promotes Lung Adenocarcinoma Invasion and Metastasis by Upregulating SNAIL

FoxG1 Facilitates Proliferation and Inhibits Differentiation by Downregulating FoxO/Smad Signaling in Glioblastoma

LncRNA FOXD1-AS1 acts as a potential oncogenic biomarker in glioma.

ASPM Activates Hedgehog and Wnt Signaling to Promote Small Cell Lung Cancer Stemness and Progression

FOXM1 promotes the progression of prostate cancer by regulating PSA gene transcription.

Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular target

FoxD2-AS1 promotes glioma progression by regulating miR-185-5P/HMGA2 axis and PI3K/AKT signaling pathway

FOXM1 promotes tumor cell invasion and correlates with poor prognosis in early-stage cervical cancer.

Data from Astrocyte Elevated Gene-1 Upregulates Matrix Metalloproteinase-9 and Induces Human Glioma Invasion

Sp1 Is Upregulated In Human Glioma, Promotes Mmp-2-Mediated Cell Invasion And Predicts Poor Clinical Outcome